Gastroenterology Fellow with a strong focus on everything liver-related

Lamia Haque, MD, MPH is an Assistant Professor of Medicine at Yale School of Medicine in the Section of Digestive Diseases, Core Faculty in the Yale Program in Addiction Medicine, Director of the Yale Clinic for Alcohol and Addiction Treatment in Hepatology, and early career clinician-investigator supported a K23 Career Development Award through the NIAAA on integrated care for alcohol-associated liver disease and alcohol use disorder in hepatology clinics.

Dr. Erin Cleveland is an assistant professor of gastroenterology and hepatology at the University of Washington, where she serves as the medical director of the Harborview Medical Center Hepatitis & Liver Clinic. Dr. Cleveland serves as a panelist for the University of Washington Project ECHO, mentoring clinicians treating viral hepatitis in underserved and rural areas of the Pacific Northwest. Her clinical interests include alcohol-associated liver disease, metabolic dysfunction-associated steatotic liver disease, and palliative care interventions in advanced liver disease.

Stephen Silva-Brave is a citizen of the Sicangu Lakota Nation who was diagnosed with alcohol-associated liver disease in 2016 at the age of 32. Since then, he has reversed the damage, become a licensed social worker, and is pursuing a PhD in Social Work. Stephen brings lived experience and cultural insight to the fight for early detection, equitable treatment, and inclusive research in liver health.

Claudio Tombazzi is a Transplant Hepatology and Hospice & Palliative Medicine physician at Vanderbilt University Medical Center. He is a 2018 graduate of the University of Tennessee Health Science Center with subsequent Internal Medicine residency, H&PM fellowship, and Gastroenterology and Liver Transplant fellowship at VUMC. His interest is on overlap of palliative medicine and hepatology with special interest on delivery of care in the outpatient setting.

Karl B. Bezak, MD, HMDC is an Assistant Professor of Medicine in the Department of Medicine, Division of General Internal Medicine, Section of Palliative Care and Medical Ethics at the University of Pittsburgh.

Nathan Baggett is an attending emergency physician for HealthPartners in St. Paul, Minnesota. He is a 2017 graduate of the University of Wisconsin School of Medicine and Public Health. He was diagnosed with primary sclerosing cholangitis in 2010. He has received 3 liver transplants in 2017 & 2018.

Teresa Davidson is the Executive Director of the Mid-South Liver Alliance located in Nashville, TN. Mid-South Liver Alliance is committed to improving, educating, advocating, and supporting children, adults, and families impacted by Chronic liver Disease in the mid-South states of TN, KY, AL, MS, AR, and LA. Before becoming the ED for the Mid-South Liver Alliance, Teresa served as a National Engagement Director South for the American Liver Foundation and as CEO for the Tennessee Kidney Foundation.

Bruce Luxon, MD, PhD is chairman and chief of service for the Department of Medicine at Georgetown University Hospital, Washington. His clinical focus is in hepatology, with expertise in autoimmune hepatitis, cholestatic liver diseases and viral hepatitis, including hepatitis B and C.

Carolin Lackner is a Professor of Pathology at the Medical University of Graz, Austria. She is specialized in hepatopathology with particular interest in steatotic liver diseases and serves as a central pathologist in clinical trials of MASH.